IL6 and chronic obstructive pulmonary disease: Because IL-1β, IL-6, and IL-23 can strongly promote the expression of Th17 cells but inhibit FOXP3 and Tregs (Morishima et al., 2009), we can easily account for the increased Th17 and decreased Tregs in COPD.